SCHEMBL5514890

SCHEMBL5514890

COc1ccc(C(C)=O)c(O)c1CCC(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
GAA P10253 2/20 0.44
NFKB1 P19838 2/20 0.44
ALOX5 P09917 2/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
PPARG P37231 2/20 0.44
PPARD Q03181 2/20 0.44
PPARA Q07869 2/20 0.44
LMNA P02545 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 1/20 0.43
GRM2 Q14416 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
BLM P54132 1/20 0.43
CYSLTR2 Q9NS75 4/20 0.42
CYSLTR1 Q9Y271 4/20 0.42
HDAC3 O15379 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10378288 0.83 PPARG (0.58) MAPTNFKB1ALOX5PPARGPPARD
SCHEMBL4487600 0.81 ALDH1A1 (0.47) MAPTGAANFKB1PPARGPPARD
SCHEMBL5513497 0.79 MEN1 (0.60) MAPTNFKB1ALOX5NFKB2RELA
SCHEMBL9578110 0.79 MEN1 (0.50) GAANFKB1ALOX5NFKB2RELA
SCHEMBL27566260 0.79 MAPT (0.45) MAPTNFKB1ALOX5NFKB2RELA
SCHEMBL5516596 0.78 MAOB (0.67) MAPTNFKB1NFKB2RELALMNA
SCHEMBL5516595 0.78 MAOB (0.67) MAPTNFKB1NFKB2RELALMNA
SCHEMBL9578114 0.77 CYP3A4 (0.54) GAANFKB1ALOX5NFKB2RELA
SCHEMBL5513536 0.75 MEN1 (0.65) MAPTALOX5PPARGPPARDPPARA
SCHEMBL3958076 0.75 MAPT (0.49) MAPTGAAALOX5PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US claimed
EP-1623704-A1 THERAPEUTIC AGENT TAKARA BIO INC. (JP) 2006-02-08 EP claimed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
EP-1623704-A1 THERAPEUTIC AGENT TAKARA BIO INC. (JP) 2006-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070092551-A1 Therapeutic agent FABP4, GPR119, IAPP MAPT 2256/4885GAA 431/4885NFKB1 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.